Last updated: February 2026
Focus: private pricing context and total cost comparison
Standard UK strengths: 0.25 mg to 2.4 mg
Important: headline figures are not always final totals
Pricing guide

Wegovy Prices & Costs UK 2026

This page is designed to help you compare Wegovy costs more intelligently. The real question is not just which provider shows the lowest visible figure, but what you would actually pay at your dose once delivery, review structure, and service differences are taken into account.

5 current UK FlexTouch pen strengths listed in the patient leaflet
4 weeks is the usual pricing frame people compare when reviewing private supply
Total cost matters more than the first number shown on a landing page
Price context

What you are actually comparing

Wegovy is commonly priced as a 4-week private supply, but providers do not all package the same things together. One site may show a lower medicine figure while another includes more of the process inside the listed amount.

  • +Medicine cost: the dose-specific price is only one part of the comparison.
  • +Delivery: some providers include it, some separate it, and some vary the charge by service level.
  • +Clinical review: repeat review or renewal requirements can alter the real monthly total.
  • +Support model: extra coaching or app support may explain why two providers look different on price.
Best rule: compare providers at the dose you are actually on, then check what the listed amount includes before treating it as the final monthly cost.
Dose structure

Current UK Wegovy dose strengths

The current UK patient leaflet lists five FlexTouch pen strengths. These are the usual dose steps people see referenced when comparing private pricing.

0.25 mg

Starter strength commonly used at the beginning of treatment.

0.5 mg

Early step-up strength after the initial start phase.

1 mg

Mid-escalation strength often used before higher maintenance steps.

1.7 mg

Higher step-up strength used before 2.4 mg for many people.

2.4 mg

The standard full maintenance strength listed in the current UK patient leaflet, where tolerated and prescribed.

Important: cost planning usually changes as dose changes. A provider that looks attractive at entry level may not remain the best fit later.
Typical pricing pattern

How private pricing often behaves across dose steps

Private pricing often rises as the prescribed strength rises, but not every provider structures its pricing in exactly the same way. The table below is a comparison framework rather than a promise of live market pricing.

Dose stepTypical phaseHow pricing usually behavesComparison note
0.25 mgStarterOften the lowest visible entry price“From” pricing is frequently built around this phase, so it can understate later costs.
0.5 mgStep-upCommonly higher than 0.25 mgUseful point to re-check total cost rather than assuming the first-month pricing continues.
1 mgStep-upOften a clearer indicator of mid-treatment spendGood stage to compare whether repeat review costs start changing.
1.7 mgStep-upUsually closer to maintenance-level pricingSome providers that look cheap early become less competitive here.
2.4 mgMaintenanceOften the key long-term comparison pointThis is where total ongoing cost matters most for many private users.
Smarter comparison: if you are already on 1.7 mg or 2.4 mg, do not let a low 0.25 mg headline figure influence your decision too much.

Live verified price comparison

Use the live comparison below to review current provider pricing data rather than relying on static examples.

Loading price comparison...

Why Wegovy prices vary between providers

Visible medicine price is only part of the explanation. Providers also differ in service structure, review process, and what they include around supply.

1

Delivery structure

Standard delivery may be included, excluded, or handled differently depending on provider model.

2

Clinical review

Some providers include more repeat review or renewal oversight inside the displayed amount.

3

Support package

Coaching, app support, or extra follow-up can change the overall pricing position.

4

Offer mechanics

Introductory or first-order figures do not always reflect the price you will face later.

NHS versus private

How NHS and private costs differ

NICE recommends semaglutide within specialist weight-management services rather than as routine open NHS access. That means NHS availability is narrower than many people expect, and private supply remains the route many users end up comparing.

  • +NHS route: depends on specialist service pathways, referral criteria, and local capacity.
  • +Private route: usually offers faster access, but ongoing costs can vary significantly between providers.
  • +NICE review point: semaglutide is reviewed after 6 months, with stopping considered if weight loss is under 5% of initial weight.
Reality check: many people researching Wegovy pricing in the UK are really comparing private access because NHS access is more limited and service-led.
Cost control

Ways to reduce your total monthly spend safely

  • +Compare true totals: medicine, delivery, repeat review, and support structure together.
  • +Check what is bundled: higher pricing can sometimes reflect services you may or may not value.
  • +Re-check at each dose step: a provider that starts well may not remain the best value later.
  • +Be careful with “from” messaging: it is often tied to the starter dose rather than long-term spend.
  • +Use regulated providers only: lower cost is never worth bypassing prescription safety checks.
Most useful question: what would I pay next month at my actual prescribed dose if I ordered from this provider today?

Cheapest verified option from current site data

Use the live lowest-price widget below as a starting point, then confirm the all-in amount and provider terms directly before ordering.

£54

Wegovy pricing FAQs

These are the pricing questions people most often get wrong when comparing private options online.

Do Wegovy prices usually increase as the dose increases? +
Often they do, but provider structures vary. The best comparison is what you would pay at your current prescribed dose after adding any delivery, review, or repeat requirements.
Why can “from £X” pricing be misleading? +
A “from” figure is often tied to the starter dose or a first-order promotion. It can understate what treatment costs once dose changes or repeat requirements begin.
What should I compare besides the visible medicine price? +
Delivery, clinical review structure, renewal requirements, support model, and whether the provider is transparent about what is included in the displayed figure.
Can I get Wegovy on the NHS instead? +
Potentially, but NICE places semaglutide within specialist weight-management services and access depends on referral pathways, local availability, and clinical eligibility.
What strengths does the current UK Wegovy pen come in? +
The current UK patient leaflet lists 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg FlexTouch pen strengths.

Useful related pages

These pages help once you move beyond the headline price question.

Comparison

Compare Wegovy prices

Review live provider data and dose views in one comparison page.

 Safety

Safety and legitimacy guide

Check provider legitimacy before treating a low price as a good deal.

 Practical use

Using Wegovy guide

Understand dose progression and how treatment stage affects pricing context.

Ready to compare verified options properly?

Use the live comparison page to review provider pricing, then check total cost, delivery, and provider terms before proceeding.

Compare Wegovy prices Safety checks first
Pricing disclaimer: Pricing, offers, and provider terms can change quickly. This page is for comparison guidance only. Always confirm the latest dose-specific price, delivery cost, and assessment requirements directly on the provider website before ordering.